期刊文献+

应用生物芯片扫描仪定量分析组织芯片荧光信号的可行性研究

Quantitative analysis of TIMP-1 expression in breast cancer by a microarray scanner as detected on tissue microarrays
下载PDF
导出
摘要 目的探讨应用生物芯片扫描仪定量检测肿瘤组织芯片荧光信号的可能性。方法将49例乳腺癌及29例癌旁组织制成组织芯片,分别采用免疫荧光组织化学技术和免疫酶组织化学技术对组织金属蛋白酶抑制剂1(TIMP1)进行染色,并应用生物芯片扫描仪和显微图像分析系统分别对上述染色结果进行定量分析,同时应用半定量积分法判定染色结果。结果组织芯片中49例癌组织TIMP1免疫荧光染色用生物芯片扫描仪定量分析的结果与免疫酶组织化学染色图像定量分析结果呈正相关(P<0.01);两种方法半定量结果检测效果也一致。结论生物芯片扫描仪可用于肿瘤组织芯片荧光信号的相对定量分析。 Objective To investigate the possibility of quantification for a target protein showed by immunostaining on tissue microarray (TMA) by use of a microarray scanner. Methods A TMA contained 13 ×6 tissue cores was constructed with tissues of 49 cases of breast cancer and 29 normal tissues. These tissues were detected for the expression of tissue inhibitor of metalloproteinase-1 ( TIMP-1 ) using immunofluorescence histochemistry (F-IHC) and immunoenzymatic histochemistry (E-IHC). The results were quantificationally analyzed by a microarray scanner and a micro-image analysis system respectively. Semi-quantitative analyses for the two different staining results were performed simultaneously. Results TIMP-1 content showed by F-IHC and quantitatively measured by microarray scanner was positively related to that showed by E-IHC and quantitatively measured by micro-image analysis ( P 〈 0. 01 ), which was positively associated with the semi-quantitative result as well. Conclusion Microarray scanners might be an useful tool for quantificational evaluation of protein contents detected on tumor TMAs.
出处 《安徽医科大学学报》 CAS 北大核心 2006年第2期181-184,共4页 Acta Universitatis Medicinalis Anhui
关键词 乳腺肿瘤 组织阵列分析 免疫组织化学 breast neoplasms tissue array analysis immunohistochemistry
  • 相关文献

参考文献4

二级参考文献28

  • 1[9]Moch H,Lononen J,Kallioniemi OP,et al. Tissue microarray:what will they bring to molecular and anatomic pathology?[J].Advan Anato Pathol, 2001,8(1):14-20.
  • 2[10]Hoos A,Urist MJ,Stojadinovic A,et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors[J].Am J Pathol,2001,158(4):1245-1251.
  • 3[11]Schraml P,Struckmann K,Bednar R,et al. CDKN2A mutation analysis,protein expression,and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas[J].Am J Pathol,2001,158(2):593-601.
  • 4[12]Miettinen HE,Jrvinen TAH,Kellner U,et al. High topoisomerase Ⅱα expression associates with high proliferation rate and poor prognosis in oligodendrogliomas[J].Neuropathol Appli Neurobiol,2000,26(6):504-512.
  • 5[13]Bowen C,Bubendorf L,James Voeller H,et al. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression[J].Cancer Res,2000,60(15):6111-6115.
  • 6[14]Mucci NR,Akdas G,Manely S,et al. Neuroendocrine expression in metastatic prostate cancer:evaluation of high throughput tissue microarrays to detect heterogeneous protein expression[J].Human Pathol,2000,31(4):406-414.
  • 7[15]Perrone EE,Theoharis C,Mucci NR,et al. Tissue microarray assessment of prostate cancer tumor proliferation in African-American and white men[J].J Natl Cancer Inst,2000,92(11):937-939.
  • 8[16]Chaib H,Rubin MA,Mucci NR,et al. Activated in Prostate Cancer:a PDZ Domain-Containing Protein Highly Expressed in Human Primary Prostate Tumors[J].Cancer Res,2001,61(6):2390-2394.
  • 9[17]Bubendorf L,Kononen J,Koivisto P,et al. Survey of amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays[J].Cancer Res,1999,59(2):803-806.
  • 10[18]Schraml P,Kononen J,Bubendorf L,et al. Tissue microarrays for gene amplification surveys in many different tumor types[J].Clin Cancer Res,1999,5(5):1966-1975.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部